The veterinary infectious diseases diagnostics market is estimated to grow at a CAGR of 8.86% to reach a market size of US$4.286 billion in 2027 from US$2.472 billion in 2020.
The prevalence of diseases such as colony collapse disorder, zoonotic diseases, rabies, and canine distemper (which is also called Hardpad disease), among some other diseases, is increasing due to the different types of bacteria, viruses, and parasites present in the surroundings and the lack of practice of proper hygiene among the animals. This leads to spreading infections and causes health-related problems for pets and livestock owners. Thus, this is encouraging them to go for regular veterinary infectious disease diagnostics checkups to keep the animal health in check and prevent them from contracting a disease, which is boosting the market growth.
Technology Launched by Major Market Players
The better, advanced, and diverse varieties of veterinary infectious disease diagnostics with enhanced features can effectively aid in the proper and efficient diagnosis and detection of diseases. These products are being launched, and products being offered by existing and new players in different markets are estimated to lead to increased adoption and propel the market growth further over the forecast period.
Some of the examples of the technology launches and animal types are as follows:
Molecular Diagnostics are estimated to increase their market share over the forecast period as the demand for faster and more effective results and the growing adoption among research centres and diagnostic laboratories.
Molecular diagnostics are a type of diagnostic test that is referred to as the detection of the genomic variants that facilitates the detection, diagnosis, sub-classification, and prognosis. It also includes monitoring the responses to therapy. Molecular diagnostics also include laboratory medicine. The technology used in genomics is increasingly essential for the provision of accurate diagnosis. Molecular diagnostics are estimated to increase their market share over the forecast period, which is attributable to the fact that infectious diseases are getting more complex and are growing increasingly common among livestock and companion animals, thus leading to rising concern among the owners. This encourages them to opt for better and more effective tests that can deliver efficient results in a short period.
Livestock animals to increase their share over the forecast period
Livestock animals are one of the key drivers for sustainable development in agriculture apart from contributing to food security, nutrition, and the alleviation of poverty and economic growth. Out of every five farm animals, about one animal is lost to serious infectious diseases, which can lead to it affecting the individuals in the population globally as they depend on a daily supply of meat, poultry, milk, and other dairy products, the quality of which can deteriorate due to disease. In addition, the cost of the burden of diseases is increasing and can lead to losses of around US$80 billion.
The livestock animals are estimated to hold a notable share over the forecast period since there has been an increase in the number of farm animals suffering from different diseases as mostly the conditions, they are held in are unhygienic and not clean. This results in the growth of bacteria and parasites in water bodies and water bowls they drink, resulting in their feed getting ridden with parasites. This is driving the requirement of diagnostics and veterinary services for these animals to prevent the risk of getting seriously ill by infections.
As the majority of nations and their states view pet care and animal care as vital services, the COVID-19 pandemic had a moderate impact on the market for veterinary infectious disease diagnostics. As a result, the pandemic had little effect on growth, since veterinarian practices were often seen as necessary industries. For instance, AmerisourceBergen Corporation 2020 claimed that several veterinarian services have demonstrated substantial improvement since December 2020, such as senior wellness bloodwork (+24%), wellness check (+14%), and heartworm testing (+5%). A rise in pet adoption has also been observed as a result of the pandemic. For instance, the Insurance Research Council reported in its October 2020 report that during the COVID-19 epidemic, over one-third (30%) of Americans adopted a pet. The uptake and demand for veterinary infectious disease diagnoses are anticipated to rise quickly as a result of the rise in pet adoption.
|Market Size Value in 2020||US$2.472 billion|
|Market Size Value in 2027||US$4.286 billion|
|Growth Rate||CAGR of 8.86% from 2020 to 2027|
|Forecast Unit (Value)||USD Billion|
|Segments Covered||Technology Type, Pathogen Type, Animal Type, End-User, And Geography|
|Regions Covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies Covered||IDEXX Laboratories Inc., Zoetis Services LLC, Heska Corporation, MEGACOR Diagnostik GmbH, Demeditec Diagnostics GmbH, DRG INSTRUMENTS GMBH, Chembio Diagnostic Systems, Inc., Virbac, Thermo Fisher Scientific, Inc., BioMerieux, Inc.|
|Customization Scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What is the size of the global veterinary infectious diseases diagnostics market?
A1. Veterinary Infectious Diseases Diagnostics Market was valued at US$2.472 billion in the year 2020.
Q2. What will be the veterinary infectious diseases diagnostics market size by 2027?
A2. The veterinary infectious diseases diagnostics market is estimated to reach a market size of US$4.286 billion by 2027.
Q3. What are the growth prospects for the veterinary infectious diseases diagnostics market?
A3. The global veterinary infectious diseases diagnostics market is estimated to grow at a CAGR of 8.86% over the forecast period.
Q4. How is the global veterinary infectious diseases diagnostics market segmented?
A4. The veterinary infectious diseases diagnostics market has been segmented by technology type, pathogen type, animal type, end-user, and geography.
Q5. What is the base year considered in the veterinary infectious diseases diagnostics market report?
A5. 2020 has been taken as the base year in the global veterinary infectious diseases diagnostics market.
1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Veterinary Infectious Diseases Diagnostics Market Analysis, by Technology Type
5.3. Molecular Diagnostics
6. Veterinary Infectious Diseases Diagnostics Market Analysis, by Pathogen Type
7. Veterinary Infectious Diseases Diagnostics Market Analysis, by Animal Type
7.2. Companion Animal
8. Veterinary Infectious Diseases Diagnostics Market Analysis, by End-User
8.2. Diagnostics Laboratories
8.3. Veterinary Clinics
8.4. Research Centres
9. Veterinary Infectious Diseases Diagnostics Market Analysis, by Geography
9.2. North America
9.2.1. United States
9.3. South America
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. United Arab Emirates
9.6. Asia Pacific
9.6.4. South Korea
10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix
11. Company Profiles
11.1. IDEXX Laboratories Inc.
11.2. Zoetis Services LLC
11.3. Heska Corporation
11.4. MEGACOR Diagnostik GmbH
11.5. Demeditec Diagnostics GmbH
11.6. DRG INSTRUMENTS GMBH
11.7. Chembio Diagnostic Systems, Inc.
11.9. Thermo Fisher Scientific, Inc.
11.10. BioMerieux, Inc.
IDEXX Laboratories Inc.
MEGACOR Diagnostik GmbH
Demeditec Diagnostics GmbH
DRG INSTRUMENTS GMBH
Chembio Diagnostic Systems, Inc.
Thermo Fisher Scientific, Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.